Discover
PLYX
Polaryx Therapeutics, Inc.
2.04
2 x 1.56
2 x 2.68
bid
ask
-
0.10
4.67%
2 @ 07:30 PM
2.04 +0.00 (0.00%)
| Ytd | -94.17% | |
| 1y | -94.17% |
2.04
day range
2.16
1.87
52 week range
35.00
| Open | 2.09 | Prev Close | 2.14 | Low | 2.04 | High | 2.16 | Mkt Cap | 101.69M |
| Vol | 81.51K | Avg Vol | 92.63K | EPS | -0.14 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.15 | 200-d Avg | 3.98 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.38M | ||
| Research and Development Expense | 719.00K | ||
| Selling, General and Administrative Expense | 661.00K | ||
| Operating Income | -1.38M | ||
| Net Income | -1.38M | ||
| Net Income Common Stock | -1.38M | ||
| Net Income Common Stock (USD) | -1.38M | ||
| Consolidated Income | -1.38M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -1.38M | ||
| Earning Before Interest & Taxes (USD) | -1.38M | ||
| Weighted Average Shares | 48.28M | ||
| Weighted Average Shares Diluted | 48.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.54M | ||
| Cash and Equivalents (USD) | 11.54M | ||
| Current Assets | 11.81M | ||
| Total Assets | 11.81M | ||
| Current Liabilities | 873.00K | ||
| Total Liabilities | 873.00K | ||
| Accumulated Retained Earnings (Deficit) | -103.56M | ||
| Shareholders Equity | 10.94M | ||
| Shareholders Equity (USD) | 10.94M | ||
| Trade and Non-Trade Payables | 779.00K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 9.83M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.46M | ||
| Issuance (Purchase) of Equity Shares | 9.83M | ||
| Net Cash Flow from Operations | -1.37M | ||